Source: Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Danoff (Baltimore, United States of America). Fibrotic CTD and interstitial pneumonia with autoimmune features (IPAF): immunosuppressive or/and anti-fibrotic treatment?. Virtual Congress 2020 – Rheumatology: understanding connective tissue disease in patients with interstitial lung disease

Member's Comments

No comment yet.

Related content which might interest you: Cytomegalovirus antigenemina in idiopathic interstitial pneumonias and collagen vascular disease-related lung diseases treated with immunosuppressive drugs Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF) Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017 Year: 2018 Impact of comorbidities in interstitial pneumonia with autoimmune features (IPAF) Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Interstitial pneumonia with autoimmune features (IPAF): a clinical entity? Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Undifferentiated systemic rheumatic diseases and overlap syndromes: when can we diagnose interstitial pneumonia with autoimmune features (IPAF)? Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Interstitial pneumonitis with autoimmune features (IPAF): a work in progress Source: Eur Respir J 2016; 47:1622-1624 Year: 2016 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Interstitial lung disease with autoimmune features Source: Eur Respir Mon 2011; 54: 104-117 Year: 2011 Characterisation of patients with interstitial pneumonia with autoimmune features Source: Eur Respir J 2016; 47:1767-1775 Year: 2016 Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Non specific interstitial pneumonia in systemic sclerosis and idiopathic interstitial pneumonia: repair or remodeling process? Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis Year: 2007 Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis Source: Eur Respir Rev, 28 (153) 190022; 10.1183/16000617.0022-2019 Year: 2019 Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Interstitial pneumonia with autoimmune features Source: Eur Respir Monogr 2019; 86: 140-152 Year: 2019 Interstitial pneumonia with autoimmune features Source: Guideline 2015 Year: 2015 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Comorbidities influence in idiopathic pulmonary fibrosis antifibrotic treatments Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019